Medical News

RSS

Cry proteins in Bacillus thuringiensis is lethal to Anopheles gambiae, the principal mosquito vector of malaria

Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have characterized a protein produced by the soil bacterium Bacillus thuringiensis subsp. israelensis (Bti), which is highly toxic against Anopheles gambiae, the principal mosquito vector of malaria.

6 Jun 2013

Study shows success in pinpointing individualized treatment for women with metastatic breast cancer

Funded by volleyball tournaments, a new study released this week shows success in pinpointing individualized treatment for women with metastatic breast cancer, according to George Mason University researchers.

6 Jun 2013

Children with co-occurrence of autism spectrum disorder and ADHD have greater impairments

In a study of the co-occurrence of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in early school-age children (four to eight years old), researchers at the Kennedy Krieger Institute found that nearly one-third of children with ASD also have clinically significant ADHD symptoms.

6 Jun 2013

Inflection Biosciences signs license agreement with CNIO to develop kinase inhibitors for cancer treatment

Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced that it has entered into a license agreement with the Spanish National Cancer Research Centre (CNIO) for the exclusive, worldwide rights to develop and commercialise several novel kinase inhibitors for the treatment of cancer.

6 Jun 2013

Consumption of cheese and other dairy products may help protect teeth against cavities

Consuming dairy products is vital to maintaining good overall health, and it's especially important to bone health. But there has been little research about how dairy products affect oral health in particular.

6 Jun 2013

Pioneering study demonstrates benefit of neuroimaging technique in identifying bipolar disorder

MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai. In a landmark study using advanced techniques, the researchers were able to correctly distinguish bipolar patients from healthy individuals based on their brain scans alone.

6 Jun 2013

Researchers discover TRF1 gene that is important for nuclear reprogramming

Researchers are still fascinated by the idea of the possibility of reprogramming the cells of any tissue, turning them into cells with the capacity to differentiate into cells of a completely different type- pluripotent cells-and they are still striving to understand how it happens.

6 Jun 2013

Instillation of chemotherapy can minimize recurrence and progression of bladder cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.

6 Jun 2013

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia.

6 Jun 2013

Beacon Health Partners, Empire BlueCross BlueShield sign Patient Centered Primary Care agreement

Beacon Health Partners, an independent physician network and Accountable Care Organization consisting of almost 300 healthcare practitioners, announced that it has signed a Patient Centered Primary Care agreement with Empire BlueCross BlueShield.

6 Jun 2013

Henry Schein Cares expands access to quality oral health care for underserved and at-risk populations

Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.

6 Jun 2013

Medicago reports positive interim results from preclinical trial for H7 VLP vaccine candidate

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").

6 Jun 2013

NeuroSigma announces launch of new website for Monarch eTNSTM System

NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the Monarch™ eTNSTM System.

6 Jun 2013

PlanSource expands strategic relationship with Aetna

PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.

6 Jun 2013

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

6 Jun 2013

First Edition: June 6, 2013

Today's headlines include a report about a new poll showing public uneasiness is increasing in regard to the health law. At the same time, the White House is stepping up its efforts encourage people to enroll in the health coverage the will be available as a result of the overhaul.

6 Jun 2013

Winners of EFIC-Grünenthal-Grant announced

For the 8th time the European Federation of IASP Chapters in cooperation with the pharmaceutical company Grünenthal Group announced the EFIC-Grünenthal-Grant (E-G-G) - a grant aimed to support young scientists at an early stage of their experimental projects on clinical and human volunteer-based pain research.

6 Jun 2013

Findings have implications for potential gene therapies for autism spectrum disorders

A gene linked to autism spectrum disorders that was manipulated in two lines of transgenic mice produced mature adults with irreversible deficits affecting either learning or social interaction.

6 Jun 2013

Seattle Children's Hospital uses IBM Big Data technology to improve treatment of young patients

IBM and Brightlight today announced that Seattle Children's Hospital is using IBM Big Data technology to improve treatment of its young patients. With over 350,000 patient visits annually and thousands of data points associated with each patient, Seattle Children's Hospital can run queries on patient data in seconds, rather than minutes, to provide quicker, more effective care and diagnosis.

6 Jun 2013

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.

6 Jun 2013

Medical News

Cry proteins in Bacillus thuringiensis is lethal to Anopheles gambiae, the principal mosquito vector of malaria

Study shows success in pinpointing individualized treatment for women with metastatic breast cancer

Children with co-occurrence of autism spectrum disorder and ADHD have greater impairments

Inflection Biosciences signs license agreement with CNIO to develop kinase inhibitors for cancer treatment

Consumption of cheese and other dairy products may help protect teeth against cavities

Pioneering study demonstrates benefit of neuroimaging technique in identifying bipolar disorder

Researchers discover TRF1 gene that is important for nuclear reprogramming

Instillation of chemotherapy can minimize recurrence and progression of bladder cancer

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

Beacon Health Partners, Empire BlueCross BlueShield sign Patient Centered Primary Care agreement

Henry Schein Cares expands access to quality oral health care for underserved and at-risk populations

Medicago reports positive interim results from preclinical trial for H7 VLP vaccine candidate

NeuroSigma announces launch of new website for Monarch eTNSTM System

PlanSource expands strategic relationship with Aetna

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

First Edition: June 6, 2013

Winners of EFIC-Grünenthal-Grant announced

Findings have implications for potential gene therapies for autism spectrum disorders

Seattle Children's Hospital uses IBM Big Data technology to improve treatment of young patients

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News